Why Quercetin Barely Absorbs — and What Actually Changes That

Quercetin is not exotic. It is in onions, capers, apples, kale and tea, and most people eating a reasonable diet take in some every day without thinking about it. Which makes its reputation among supplement buyers slightly odd, because the plain compound in a capsule is one of the worst-absorbed things on the shelf — bioavailability from unformulated quercetin has been reported at under one percent.

That gap between "abundant in food" and "barely absorbed from a capsule" is the whole subject. It is also a useful case study, because quercetin is one of the few ingredients where researchers have compared the ways of fixing the problem, in humans, against each other. The answer is not the one the labels emphasise.

Two problems, and only one of them is solubility

Quercetin's first difficulty is physical. The bare molecule — the aglycone, meaning the form with no sugar attached — dissolves poorly in water, and a compound that will not dissolve in the watery contents of the small intestine cannot present itself to the cells that would absorb it. Everything that happens to a solid particle of quercetin in your gut is downstream of that.

The second difficulty is that your body treats it as something to be processed and removed. Flavonoids that do get absorbed are rapidly conjugated — glucuronidated and sulfated — in the intestinal wall and the liver, and the conjugates are cleared. This matters for how you read any absorption claim: raising the amount that crosses the gut wall does not switch off the machinery waiting on the other side.

Keep those two apart in your head, because delivery systems only address the first one. A carrier can make a stubborn molecule disperse. It cannot talk your liver out of conjugating what arrives.

In food, quercetin never travels alone

Here is the detail that reframes the category. In plants, quercetin is almost always attached to a sugar, and which sugar it is attached to changes its absorption more than most formulation technology does.

A 2025 systematic review and meta-analysis pooled 31 human intervention studies on quercetin bioavailability and found a clean hierarchy. Quercetin bound to oligoglucosides was roughly twice as bioavailable as quercetin-3-O-glucoside, about ten times more than quercetin-3-O-rutinoside, and around twenty times more than the bare aglycone. Same molecule doing the work; radically different amounts of it arriving.

Lecithin, and what a phospholipid actually buys you

The formulation approach with the best human data for quercetin is not a sealed vesicle but a phospholipid complex — quercetin bound with food-grade lecithin, sold as a phytosome. In a randomised three-way crossover in twelve fasted healthy volunteers, that formulation produced plasma levels reported as up to twenty times those normally seen after a dose of unformulated quercetin, with dose-proportional behaviour across the two doses tested.

Two honest footnotes. The authors were employed by the company that developed the formulation, which is common in this literature and worth knowing. And twelve people in a single-dose pharmacokinetic study tells you about absorption, not about what any of it does over weeks — the trial measured blood levels, not outcomes.

Still, the mechanism is consistent with everything else here. Lecithin is an emulsifier. What it does for a poorly-soluble flavonoid is keep it dispersed through the detergent-rich environment of the small intestine, which is precisely the bottleneck quercetin has.

The counter-example that keeps everyone honest

If phospholipids reliably fixed absorption, curcumin would be the success story. It is the most-formulated poorly-absorbed compound in the industry, and it has the most brutal head-to-head trial.

Twelve healthy adults took 207 mg of curcumin as eight different formulations, in a randomised double-blind crossover. Micellar curcumin raised the 24-hour AUC 57-fold against the native extract. A gamma-cyclodextrin complex managed 30-fold. Phytosomes and submicron particles produced numerical increases of 7.5-fold and 6.5-fold that did not reach significance. Liposomal curcumin produced no increase at all — its mean AUC came in slightly below the plain extract. Piperine, the classic adjuvant, did nothing measurable either.

The property that separated winners from losers was how much compound stayed dissolved after simulated digestion: 80% for the micellar format, 3.6% for the liposomal one. The trial was part-funded by companies including the maker of a micellar product, which you should factor in — but the ranking is hard to explain away, and it is the only human experiment that puts these formats side by side.

The lesson generalises better than either result. "Wrapped in phospholipid" is not a specification. What matters is whether a particular formulation of a particular compound survives digestion still dissolved, and that is an empirical question with different answers for different ingredients.

What to do with this in a supermarket

The bottom line

Quercetin absorbs badly because it barely dissolves, and the fixes that work are the ones that keep it in solution long enough to be taken up. The sugar it comes attached to moves absorption by roughly twenty-fold. A lecithin complex moves it by a similar order in the best human data available. A sealed liposome, on the evidence from the closest comparable compound, is not automatically in that league — which is exactly why the ingredient and the formulation have to be judged together rather than by the word on the front.

In Agen's range, liposomal quercetin and liposomal curcumin use phospholipid delivery for compounds that genuinely have a dispersal problem, alongside other poorly-soluble plant compounds such as EGCG and resveratrol. For the mechanism underneath all of it, see what the gut actually does to a liposome; for the ingredient with the strongest absorption data, the vitamin C trials; and for how to judge a product on the shelf, our guide to liposomal supplements.